MarketCapExport financials
AnPac Bio-Medical Science Co., Ltd. (ANPC)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
AnPac Bio-Medical Science Co., Ltd. Balance Sheet 2022-2011 | ANPC
Brief overview of AnPac Bio-Medical Science Co., Ltd.'s assets and capital
The balance sheet is assessed across five available annual reports spanning 2018 to 2022.
Assets fell from 52.8 million CNY to 40.5 million CNY. This may reflect either deliberate optimization or a reduction in business scale.
Growth in the asset base was not matched by liabilities: -23.3% versus -33.6%. The balance sheet moved in a more conservative direction.
Negative shareholders' equity signals an accumulated net asset deficit and calls for particular caution.
Cash accounts for 4.6% of assets versus 24.4% initially. The change indicates the degree of financial flexibility.
The balance sheet carries negative retained earnings of -577.5 million CNY. The figure may result from accumulated losses or an active capital return policy.
Overall picture
Taken together, AnPac Bio-Medical Science Co., Ltd.'s balance sheet indicators point to elevated risk. Asset growth does not offset weak funding sources.
Annual Balance Sheet AnPac Bio-Medical Science Co., Ltd.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
5.43 M | - | - | - | - | 1.09 M | - | - | - | - | - | - |
Long Term Debt |
6.52 M | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
784 K | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | 3.09 M | 2.71 M | 3.72 M | 15.3 M | - | - | - | - | - | - |
Total Current Liabilities |
42.3 M | 62.9 M | 43.5 M | 66.2 M | 71.4 M | - | - | - | - | - | - | - |
Total Liabilities |
49.9 M | 66.2 M | 46.6 M | 68.9 M | 75.2 M | 50.7 M | - | - | - | - | - | - |
Deferred Revenue |
4.96 M | 4.17 M | 3.68 M | 2.45 M | 4.31 M | 1.98 M | - | - | - | - | - | - |
Retained Earnings |
-578 M | -476 M | -357 M | -276 M | -174 M | -132 M | - | - | - | - | - | - |
Total Assets |
40.5 M | 67.5 M | 49.9 M | 53 M | 52.8 M | 60.1 M | - | - | - | - | - | - |
Cash and Cash Equivalents |
1.87 M | 9.25 M | 3.02 M | 6.12 M | 12.9 M | 11.4 M | - | - | - | - | - | - |
Book Value |
-9.4 M | 1.32 M | 3.28 M | -15.9 M | -22.4 M | 9.5 M | - | - | - | - | - | - |
Total Shareholders Equity |
-13.7 M | -4.5 M | 2.95 M | -16 M | -22.4 M | 9.5 M | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in CNY currency
Quarterly Balance Sheet AnPac Bio-Medical Science Co., Ltd.
| 2023-Q2 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
37 K | 6.52 M | - | 7.53 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
66.1 M | 49.9 M | - | 45.5 M | - | 66.2 M | - | 48.4 M | - | 46.6 M | - | - | - | 68.9 M | - | - | - | 75.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
479 K | 4.96 M | - | 4.56 M | - | 4.17 M | - | 5.09 M | - | 3.68 M | - | - | - | 2.45 M | - | - | - | 4.31 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-648 M | -578 M | - | -524 M | - | -476 M | - | -414 M | - | -357 M | - | - | - | -276 M | - | - | - | -174 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
178 M | 40.5 M | - | 61.1 M | - | 67.5 M | - | 69 M | - | 49.9 M | - | - | - | 53 M | - | - | - | 52.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
495 K | 1.87 M | - | 6.89 M | - | 9.25 M | - | 8.58 M | - | 3.02 M | - | 9.97 M | - | 6.12 M | - | - | - | 12.9 M | - | - | - | 11.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
112 M | -9.4 M | - | 15.6 M | - | 1.32 M | - | 20.5 M | - | 3.28 M | - | - | - | -15.9 M | - | - | - | -22.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
92.5 M | -13.7 M | - | 10.5 M | - | -4.5 M | - | 20.9 M | - | 2.95 M | - | 24.6 M | - | -16 M | - | - | - | -22.4 M | - | - | - | 9.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in CNY currency
Balance Sheet is a fundamental financial report of AnPac Bio-Medical Science Co., Ltd., providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
USA
Israel
Irlanda
Britain
Schweiz
